Insmed

INSM

Insmed
$31.59 $1.06 0.0%
BATS BZX Real Time Price as of April 23, 2019, 4:30 p.m. View Interactive INSM Charts

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs.

News & Analysis: Insmed

All

Market Moves

Earnings










This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.


Interactive Chart